Cary Street Partners Investment Advisory’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,759
Closed -$223K 688
2025
Q3
$223K Sell
1,759
-29
-2% -$3.45K 0.09% 243
2025
Q2
$219K Buy
+1,788
New +$204K 0.11% 218
2023
Q4
Sell
-537
Closed -$36.1K 934
2023
Q3
$36.1K Hold
537
﹤0.01% 954
2023
Q2
$36.4K Buy
+537
New +$33.7K ﹤0.01% 897

Other funds holding EHC

Cary Street Partners Investment Advisory's EHC Position: Q4 2025 in Review

Cary Street Partners Investment Advisory sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 1,759 shares — an estimated $223K sold.

Cary Street Partners Investment Advisory first reported a position in EHC in Q2 2023 and held it in 4 quarters. The position peaked at $223K in Q3 2025. 593 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Cary Street Partners Investment Advisory reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,759 Encompass Health shares in Q4 2025, an estimated $223K.
  • Cary Street Partners Investment Advisory first reported a position in Encompass Health in Q2 2023 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Encompass Health position peaked at $223K in Q3 2025.
  • 593 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2025, filed 9 Feb 2026.